Questions discussed in this category
Specifically, on re-staging imaging, would the tumor regression be strictly defined by reduction in cranio-caudal direction only, or would other measu...
And if so, which one? Does nodal status affect your decision? Is there any evidence for ctDNA in this space?
Would chemoRT be preferred over surgery if there is LVI or PNI?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
...
And if so, would you offer it pre or post-metastasectomy? Would time to recurrence or ctDNA play a role?
Would you approach with curative intent with locoregional treatment or systemic treatment alone?
In general: when would you recommend adjuvant radiation and capecitabine for a colon cancer?
Is there a potential role for concurrent radiation therapy? What if the tumor is BRAF mutated?
Staging/pre-op MRI only showed mild non-specific thickening.
And is it different when using pembrolizumab or a combination of ipilimumab/nivolumab?
Do you add VEGFR/EGFR antibodies? Or switch to another regimen?
Do you use the same high risk factors as adenocarcinoma when deciding on adjuvant treatment for early stage disease?
> 30s, female with metastatic colon cancer. Presented with a headache. Metastatic hemorrhagic mets per MRI 10/2022. Had radiation. Kras mutated, Br...
How do you reconcile the differences between the two studies?
Would sidedness matter? Do you use ctDNA assays to evaluate for acquired RAS mutations to guide this decision?
Does the patient's young age affect your decision when applying data from the IDEA collaboration?
Instead of FOLFOXIRI and bevacizumab as per TRIBE trial
Do the overall survival results of PARADIGM presented at ASCO 2022 change the standard of care?
Would you advocate for a targeted gene approach or a fully comprehensive NGS panel?
Would you recommend pembrolizumab prior to surgery? Or after? Is there a role for FOLFOX?
Would you offer EGFR inhibitors as second line?
Specifically, would you consider either neoadjuvant or adjuvant immunotherapy in this setting, or only after recurrence?
For example, portion is seen above and below the mesorectal fascia. Do you feel comfortable treating as colon cancer with surgery upfront?
Would you consider the BEACON regimen (i.e., encorafenib/binimetinib + cetuximab) in this setting?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
If you do not use prophylaxis, what skin care strategy do you employ?
Would you debulk with neoadjuvant therapy to achieve resectability?
Would you recommend 6 months of FOLFOX or just surveillance?
G1 neuropathy and G3 neutropenia were observed with cycle 12 FOLFOX + bev.
Would you reintroduce oxali at a lower dose or switch to irinotecan+EGFRi ...
Of note - the tumor tissue biopsy NGS did not show KRAS or BRAF mutations. Microsatellite stable. Patient received first line FOLFOXIRI + Avastin .
This involves the primary site responding but progression with new bone marrow involvement with resulting cytopenias.
Colleagues in surgery have raised concerns about post radiation effects in the pelvis with the ordering of short course RT->chemo ->surgery.
eg LVI/PNI, poorly differentiated? If so, what regimen and for how long?
Is there a subset of patients you would avoid neoadjuvant CRT and operate first?
Benefit of oxaliplatin in patients >70 years of age is not proven and only 5FU/capecitabine in a MSI-H tumor is of questionable efficacy. What woul...
Would you use a small cell regimen over a more traditional FOLFOX-esque approach?
No high risk features such as: lymphovascular invasion, perforation, or involved margins
Would you consider adjuvant chemotherapy?
Would you use FOLFIRINOX as in Prodige 23 or FOLFOX as in RAPIDO?
When would you consider use of ctDNA to help with this decision?
How would the sidedness of the tumor, BRAF, RAS,HER2 or MSI status affect your decision?
Would you consider using PARP Inhibitor in this situation?
If so, which patients are the best candidates?
Would you use dual agent chemotherapy such as FOLFIRI, combination of chemo with biologic- IRI/Cetux or all 3 drugs simultaneously? How would sidednes...
Would you continue to trend ctDNA to detect early recurrence?
Do you routinely test for this with a re-biopsy?
Given that majority of benefit is derived from the capecitabine, would this be an acceptable option to decrease patient contact with the healthcare sy...
If so, how much systemic therapy would you give before considering surgery?
Would presence of features considered high risk in stage II sway your interpretation of the IDEA trial?
Would you choose to use IO or BRAF directed therapy based on BEACON? Or would you continue to use cytotoxic chemotherapy?
Package insert indicates discontinuing bevacizumab in PE and there are no guidelines on re-challenging after acute clot is managed.
In practice, does starting with chemoradiation followed by chemotherapy result in a significant delay in initiating chemotherapy or a patient's abilit...
If so, what agent(s) would you consider given the concurrent amplification and mutation?
The German trial included patients with tumors up to 16cm from the anal verge, while the Swedish trial update found no local control benefit for tumor...
Does the pathology outweigh usual staging and risk factors?
The NCCN seems to make its recommendation based on extrapolation from colon cancer, but those patients are not treated with pre-op chemoRT.
PDL1 is > 50%. There was no perforation or lymph node involvement.
Has the utility of BRAF in CRC expanded beyond guiding prognosis? Is there a role in non-metastatic CRC?
Does the presence of BRAF mutation affect your decision?
Do you test for COX-2 and PIK3CA mutations?
Are these patients better candidates for preop chemotherapy alone?
If a patient with stage II or III colon adenocarcinoma who presents to your clinic 12-16 weeks after surgical resection do you give adjuvant chemother...
Is there a change in approach over the past few years? Would there be a role for the 12-gene recurrence score?
Since some prior subset analyses have suggested that oxaliplatin may not improve outcomes of older patients with colon cancer in the adjuvant settin...
Does the recent Hopkins trial of pembrolizumab change your management of these patients?
If so, what is your preferred regimen?
211502071219802205602011215342197901893218513183771845918379182051760513370533617895178861787016605176461753817546162211728211088171551694016893169305132162721620116135155641606215520130905971129721546515919159421586613316154671289614960147715677143661436013641629113008120721049512856101471020011916117871170910234765110480978471386525790671139246603287158161833083617274597257227232733644466916965686067146500603465936254476254036030620601095158225679116048095178448042883639376257923677571131728756574
Papers discussed in this category
J. Clin. Oncol.,
Lancet Gastroenterol Hepatol, 2019 Jul 29
JAMA oncology, 2018-06-14
J. Clin. Oncol., 2019 Oct 08
The New England journal of medicine, 1985-06-06
Cancer,
Eur J Surg Oncol,
Ann. Surg. Oncol., 2010 Sep 21
Clin Epidemiol, 2012 Nov 07
HPB : the official journal of the International Hepato Pancreato Biliary Association, 2016-03
Lancet Oncol., 2016-06-01
Nature, 2018-02-08
The Lancet. Oncology, 2019-04
Neuroendocrinology, 2019 Aug 21
Ann. Surg., 2019 Aug 30
Expert Opin Biol Ther, 2019 Mar 27
J. Clin. Oncol., 2019 Oct 14
Lancet Oncol., 2015 Aug 31
Lancet Oncol., 2020 Mar 09
JAMA, 2017-06-20
Annals of oncology : official journal of the European Society for Medical Oncology, 2017-08-01
Lancet Oncol, 2014 Jul 31
J Clin Oncol, 2022 Jun 06
J Clin Oncol, 2007 May 01
J. Clin. Oncol., 2003 Sep 08
N. Engl. J. Med.,
N Engl J Med, 2015 Jun 25
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-03-10
N. Engl. J. Med., 2019 Sep 30
J. Clin. Oncol., 2019 May 31
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-08-10
Nature, 2017-08-10
Oncogene, 2018 Mar 15
Clin Cancer Res, 2019 Sep 12
JCO Precis Oncol, 2019 Aug 05
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-11-01
N. Engl. J. Med.,
Br. J. Cancer,
Eur. J. Cancer, 2017-01-01
Int. J. Cancer, 2017 Jun 08
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-01-20
J. Clin. Oncol., 2012-06-01
Lancet (London, England), 2007-12-15
Annals of surgery, 1999-07
Journal of the National Cancer Institute, 2000-03-01
Diseases of the colon and rectum, 2009-04
Radiother Oncol, 2012 Nov 28
J Gastrointest Oncol,
Radiat Oncol J, 2019 Jun 30
Radiat Oncol, 2019 Jan 16
Radiat Oncol, 2014 Jul 22
Radiat Oncol, 2016 Sep 05
British journal of cancer, 2011-02-01
Anticancer Res.,
Annals of surgical oncology, 2018-08
Biosci. Rep.,
J Natl Compr Canc Netw,
J Natl Compr Canc Netw,
Anticancer Res.,
Cancer, 2018-06-01
N. Engl. J. Med., 2019 Jun 02
Journal of the National Cancer Institute, 2018-11-01
J. Clin. Oncol., 2020 Jan 24
Invest New Drugs, 2012 Oct 09
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-07-10
Science translational medicine, 2016-07-06
JAMA oncology, 2019-05-09
JAMA oncology, 2019-05-09
J. Clin. Oncol., 2012 Aug 20
Gut, 2018 Feb 02
Lancet Oncol, 2020 Dec 07
Ann Oncol,
Lancet Oncol, 2021 Apr 13
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-07-10
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-10-01
Journal of the National Cancer Institute, 2012-02-08
Annals of oncology : official journal of the European Society for Medical Oncology, 2015-04
Cancers (Basel), 2021 Jan 15
ESMO Open,
J Clin Oncol,
JAMA oncology, 2018-09-01
Human pathology, 2019-06
Oncoimmunology, 2018
Pancreas, 2010-08
Annals of surgical oncology, 2006-03
Neuroendocrinology, 2012 Feb 15
Neuroendocrinology, 2015 Sep 10
Cancer cell, 2018-05-14
Annals of oncology : official journal of the European Society for Medical Oncology, 2019-07-01
Lancet Oncol, 2020 Sep 10
JAMA Oncol,
Cancer Discov, 2020 Nov 02
J Gastrointest Oncol,
Hum Mutat,
International journal of radiation oncology, biology, physics, 2011-01-01
Lancet (London, England), 2009-03-07
International journal of radiation oncology, biology, physics, 1989-02
Int J Radiat Oncol Biol Phys,
Curr Health Sci J, 2018 Jan 05
Clin Cancer Res, 2020 Mar 6
N Engl J Med,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002-12-01
BJS open, 2021 Nov 09
PLoS One, 2021 Mar 26
Eur J Surg Oncol, 2021 Jul 31
BMJ Open, 2021 Sep 24
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-03-10
N Engl J Med, 2018 Mar 29
J Clin Oncol, 2020 Dec 23
Nat Med, 2020 Apr 06
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-10-10
JAMA oncology, 2018-03-01
J Clin Oncol, 2015 Nov 02
J Natl Cancer Inst, 2016 Feb 01
N Engl J Med, 2022 Jun 05
N Engl J Med, 2022 Jun 04
JCO precision oncology, 2022 Jul
Pract Radiat Oncol, 2020 Oct 21
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007-06-01
Cancer, 2007-08-01
Journal of gastrointestinal oncology, 2017-12
Cardiooncology, 2019
Cardiol Clin, 2019 Aug 26
JACC CardioOncol, 2021 Mar 16
The New England journal of medicine, 2013-10-31
Lancet, 2021 Jun 05
Eur J Cancer, 2018 Aug 24
NEJM Evidence, 2022 Jun 1
Clinics in colon and rectal surgery, 2019-05
N Engl J Med, 2022 Nov 03
J Gastrointest Oncol, 2020 Feb
Front Oncol, 2023 Feb 02
JAMA Oncol, 2019 Mar 01
Nat Med, 2022 Aug 01
Br J Cancer, 2020 Aug 31
Target Oncol, 2021 Oct 31
JAMA Oncol, 2021 Oct 01
Ann Oncol, 2019 Feb 01
Lancet Oncol, 2020 Jan 31
Nat Med, 2023 Jan 16
Cancer Sci, 2021 Jun 07
J Natl Cancer Inst, 2021 Feb 01
J Clin Oncol, 2021 Oct 12
Nat Cancer, 2020 Aug 03
Cancers (Basel), 2021 Feb 21
J Neurooncol, 2017 Nov 23
Annals of surgery, 2006-12
Annals of surgical oncology, 2013-07
Annals of surgical oncology, 2010-01
Diseases of the colon and rectum, 1999-09
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-09-10
Dermatol Pract Concept, 2019 Jan 31
Clin Cancer Res, 2013 Jul 05
N Engl J Med, 2023 Jun 04
Lancet Oncol, 2021 May 04
Lancet Oncol, 2023 Jun 02
Oncology (Williston Park), 2022 Feb 08
Insights Imaging, 2018 Nov 14
JAMA, 2021 Feb 16
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-05-15
Lancet Oncol., 2011 May 17
Lancet (London, England), 2009-03-07
Ann Surg, 2011 Apr
JAMA Oncol, 2019 Jul 01
J Clin Oncol, 2023 Jun 19
Clinical cancer research : an official journal of the American Association for Cancer Research, 2008-01-15
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 Jan 29
Journal of geriatric oncology, 2020 Jun 21
Medical oncology (Northwood, London, England), 2018 May 31
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Jan 09
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 May 15
Nature communications, 2023 Jun 07
Diseases of the colon and rectum, 1993-01
Cancer, 1976 Apr
Annals of oncology : official journal of the European Society for Medical Oncology, 2011 Apr 29
Digestion, 2018 Jun 05
British journal of cancer, 2016 Mar 15
Nature medicine, 2008-09
Annals of oncology : official journal of the European Society for Medical Oncology, 2017-06-01
The Cochrane database of systematic reviews, 2015 Dec 10
Japanese journal of clinical oncology, 2002 Feb
British journal of cancer, 2019 Apr 24
JAMA oncology, 2017-02-01
Nature medicine, 2024 Feb 12
BMC medicine, 2023 Jan 04